# A Study of Paliperidone Palmitate in Patients With Schizophrenia Previously Unsuccessfully Treated by Oral Antipsychotics

> **NCT01685931** · PHASE4 · COMPLETED · sponsor: **Xian-Janssen Pharmaceutical Ltd.** · enrollment: 617 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** Paliperidone Palmitate

## Key facts

- **NCT ID:** NCT01685931
- **Lead sponsor:** Xian-Janssen Pharmaceutical Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-11
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 617 (ACTUAL)
- **Last updated:** 2016-01-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01685931

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01685931, "A Study of Paliperidone Palmitate in Patients With Schizophrenia Previously Unsuccessfully Treated by Oral Antipsychotics". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01685931. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*